Delivery Order SPE2DB20D3103-SPE2DB26FL4K9
- Not listed
- The Defense Logistics Agency awarded a $4,425.45 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Imuran 50 mg, with a completion date of September 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed as a child contract under AmerisourceBergen's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This delivery order represents a routine...
- The Defense Logistics Agency awarded a $8,222.10 delivery order to AmerisourceBergen Drug Corp for the supply of Imuran 50 mg tablets (100-count units) under a firm fixed-price contract type. This non-set-aside competitive award was issued on October 30, 2025, with an ultimate completion date of October 31, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $2,626.61 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Imuran 50 mg on October 29, 2025, with an ultimate completion date of October 30, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division located in Conshohocken, Pennsylvania. Imuran is an immunosuppressant medication commonly used to treat autoimmune conditions and prevent organ...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for azathioprine 100 mg tablets (100 count) on September 24, 2025, with a ceiling value of $2,122.54 and ultimate completion date of September 25, 2025. This competitively awarded, firm fixed price delivery order was fulfilled from the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. The contract carries no set-aside designation. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,278.02 to AmerisourceBergen Drug Corp for the supply of Azathioprine 50 mg tablets (100 count) on September 17, 2025, with a completion date of September 18, 2025. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a firm fixed-price delivery order valued at $17,524.44 to AmerisourceBergen Drug Corp on July 27, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,646.92 by the Defense Logistics Agency's Medical Supply Chain on July 14, 2025, with an ultimate completion date of July 15, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which is valued at...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,974.65 by the Defense Logistics Agency's Medical Supply Chain on July 4, 2025, with an ultimate completion date of July 7, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a continuation of the company's extensive federal pharmaceutical supply portfolio. The delivery order is...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $7,126.93 by the Defense Logistics Agency's Medical Supply Chain on June 16, 2025, with an ultimate completion date of June 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $67,151.06 by the Defense Logistics Agency's Medical Supply Chain on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4K9Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,743.92 to AmerisourceBergen Drug Corp for the supply of Imuran 50 mg tablets (100 count) on October 30, 2025, with an ultimate completion date of October 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters and primary distribution center. This delivery order exemplifies the operational scope of AmerisourceBergen's comprehensive pharmaceutical prime vendor agreement with DLA, which supports military healthcare systems globally. As a major pharmaceutical distributor, AmerisourceBergen supplies an extensive portfolio of medications and medical supplies across multiple therapeutic domains to the Defense Health Agency and other federal healthcare customers. The SPE2DX contract serves as a flexible vehicle enabling rapid fulfillment of critical pharmaceutical needs throughout the military medical supply chain, with the company demonstrating consistent capability to meet federal procurement requirements through competitive award processes and diverse product delivery ranging from small-value transactions to orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.7k | 10/30/25 |